Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
Lymphokine Research|January 1, 1988
Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in cultureM G Rosenblum, N J Donato, J U Gutterman
Seminars in Hematology|July 1, 1990
Update on therapeutic options for chronic myelogenous leukemiaM Talpaz, H Kantarjian, R Kurzrock, et al.
Seminars in Oncology|December 1, 1984
Biologic therapy of hairy cell leukemiaJ R Quesada, E M Hersh, J U Gutterman
Immunological Communications|January 1, 1973
Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solutionG M Mavligit, J U Gutterman, E M Hersh
Canadian Medical Association Journal|February 3, 1979
Cancer immunotherapyS P Richman, J U Gutterman, E M Hersh
British Journal of Haematology|October 1, 1991
Interferon alpha in the therapy of CMLM Talpaz, H Kantarjian, R Kurzrock, et al.
The Medical Clinics of North America|September 1, 1976
Immunotherapy of leukemiaE M Hersh, J U Gutterman, G M Mavligit
World Journal of Surgery|July 30, 1979
Combined modality therapy of malignant melanomaE M Hersh, J U Gutterman, C M McBride
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress reportJ R Quesada, D A Swanson, J U Gutterman
American Journal of Clinical Oncology|January 1, 1991
Cytokines in tumor therapy. Interleukin-3R Kurzrock, Z Estrov, M Talpaz, et al.
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
Lymphokine Research|January 1, 1988
Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in cultureM G Rosenblum, N J Donato, J U Gutterman
Seminars in Hematology|July 1, 1990
Update on therapeutic options for chronic myelogenous leukemiaM Talpaz, H Kantarjian, R Kurzrock, et al.
Seminars in Oncology|December 1, 1984
Biologic therapy of hairy cell leukemiaJ R Quesada, E M Hersh, J U Gutterman
Immunological Communications|January 1, 1973
Separation of viable from non-viable tumor cells using Ficoll-Hypaque density solutionG M Mavligit, J U Gutterman, E M Hersh
Canadian Medical Association Journal|February 3, 1979
Cancer immunotherapyS P Richman, J U Gutterman, E M Hersh
British Journal of Haematology|October 1, 1991
Interferon alpha in the therapy of CMLM Talpaz, H Kantarjian, R Kurzrock, et al.
The Medical Clinics of North America|September 1, 1976
Immunotherapy of leukemiaE M Hersh, J U Gutterman, G M Mavligit
World Journal of Surgery|July 30, 1979
Combined modality therapy of malignant melanomaE M Hersh, J U Gutterman, C M McBride
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress reportJ R Quesada, D A Swanson, J U Gutterman
American Journal of Clinical Oncology|January 1, 1991
Cytokines in tumor therapy. Interleukin-3R Kurzrock, Z Estrov, M Talpaz, et al.
Pageof 34